Belite Bio BLTE
NASDAQ BLTE
$162.36 -0.62 (-0.38%)
As of: Oct 2, 2026 · 2:13 PM EDT

Belite Bio (BLTE) Depreciation and Depletion (2024 - 2025)

Updated

Belite Bio's Depreciation and Depletion came in at $45,000 for Q4 2025, up 4.7% from $43,000 a year earlier.

Analysis

Belite Bio (BLTE) Depreciation and Depletion (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio's Depreciation and Depletion was $172,000, up 4.9% from FY2024.

  • Depreciation and Depletion has increased in each of the last five years, with a five-year compound annual growth rate of 58.9% (FY2020 to FY2025).
  • Going back by year, Depreciation and Depletion was $164,000 in FY2024 (+18.0%), $139,000 in FY2023 (+117.2%), $64,000 in FY2022 (+113.3%) and $30,000 in FY2021 (+76.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Belite Bio 6.68 Bn 6.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45,000.00
Dec 31, 2024 43,000.00
API Access

Belite Bio Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=BLTE&period=max&api_key=YOUR_API_KEY